|
Platelet function inhibitors
Citations 101-110 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Vascular Medicine
Adenovirus-Mediated Transfer of Human Placental Ectonucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation In Vitro and Arterial Thrombus Formation In Vivo
- Eiji Furukoji, Masanori Matsumoto, Atsushi Yamashita, Hideo Yagi, Yoshihiko Sakurai, Kousuke Marutsuka, Kinta Hatakeyama, Kazuhiro Morishita, Yoshihiro Fujimura, Shozo Tamura, and Yujiro Asada
Circulation 2005;111:808-815; published online before print as doi:10.1161/01.CIR.0000155239.46511.79
[Abstract]
[Full text]
- Articles
Adenovirus-Mediated Transfer of Human Placental Ectonucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation In Vitro and Arterial Thrombus Formation In Vivo
- Eiji Furukoji, Masanori Matsumoto, Atsushi Yamashita, Hideo Yagi, Yoshihiko Sakurai, Kousuke Marutsuka, Kinta Hatakeyama, Kazuhiro Morishita, Yoshihiro Fujimura, Shozo Tamura, and Yujiro Asada
Circulation published February 7, 2005, doi:10.1161/01.CIR.0000155239.46511.79
[Abstract]
- Editorials
Diabetes, Coronary Intervention, and Platelet Glycoprotein IIb/IIIa Blockade: The Triad Revisited
- W.H. Wilson Tang and A. Michael Lincoff
Circulation 2004;110:3618-3620, doi:10.1161/01.CIR.0000151355.07568.B4
[Full text]
- Late-Breaking Clinical Trials
Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel
- Julinda Mehilli, Adnan Kastrati, Helmut Schühlen, Alban Dibra, Franz Dotzer, Nicolas von Beckerath, Hildegard Bollwein, Jürgen Pache, Josef Dirschinger, Peter P. Berger, Albert Schömig for the Intracoronary Stenting and Antithrombotic Regimen: Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics (ISAR-SWEET) Study Investigators
Circulation 2004;110:3627-3635; published online before print as doi:10.1161/01.CIR.0000148956.93631.4D
[Abstract]
[Full text]
- Clinician Update
Platelet Function Testing in Cardiovascular Diseases
- Alan D. Michelson
Circulation 2004;110:e489-493e, doi:10.1161/01.CIR.0000147228.29325.F9
[Full text]
- Articles
Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel
- Julinda Mehilli, Adnan Kastrati, Helmut Schühlen, Alban Dibra, Franz Dotzer, Nicolas von Beckerath, Hildegard Bollwein, Jürgen Pache, Josef Dirschinger, Peter P. Berger, Albert Schömig for the Intracoronary Stenting and Antithrombotic Regimen: Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics (ISAR-SWEET) Study Investigators
Circulation published November 7, 2004, doi:10.1161/01.CIR.0000148956.93631.4D
[Abstract]
- AHA Scientific Statements
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
- Jane W. Newburger, Masato Takahashi, Michael A. Gerber, Michael H. Gewitz, Lloyd Y. Tani, Jane C. Burns, Stanford T. Shulman, Ann F. Bolger, Patricia Ferrieri, Robert S. Baltimore, Walter R. Wilson, Larry M. Baddour, Matthew E. Levison, Thomas J. Pallasch, Donald A. Falace, and Kathryn A. Taubert
Circulation 2004;110:2747-2771, doi:10.1161/01.CIR.0000145143.19711.78
[Abstract]
[Full text]
- Coronary Heart Disease
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
- J.P. Collet, G. Montalescot, B. Blanchet, M.L. Tanguy, J.L. Golmard, R. Choussat, F. Beygui, L. Payot, N. Vignolles, J.P. Metzger, and D. Thomas
Circulation 2004;110:2361-2367; published online before print as doi:10.1161/01.CIR.0000145171.89690.B4
[Abstract]
[Full text]
- Articles
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
- J. P. Collet, G. Montalescot, B. Blanchet, M. L. Tanguy, J. L. Golmard, R. Choussat, F. Beygui, L. Payot, N. Vignolles, J. P. Metzger, and D. Thomas
Circulation published October 11, 2004, doi:10.1161/01.CIR.0000145171.89690.B4
[Abstract]
- Coronary Heart Disease
Loading With 600 mg Clopidogrel in Patients With Coronary Artery Disease With and Without Chronic Clopidogrel Therapy
- Adnan Kastrati, Nicolas von Beckerath, Alexander Joost, Gisela Pogatsa-Murray, Olga Gorchakova, and Albert Schömig
Circulation 2004;110:1916-1919; published online before print as doi:10.1161/01.CIR.0000137972.74120.12
[Abstract]
[Full text]
|
|
